Saffron: Benefits, Forms, Dosing, and Side Effects

Table of Contents

• Current evidence position
• Key safety points
• Brad's videos on this topic
• Overview
• Forms and Bioavailability
• Evidence for Health Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Current evidence position

Brad has not made a video on this topic; this is a summary of the evidence, not his view. Meta-analyses of small, short trials, many run in Iran, found that saffron eased symptoms of mild to moderate depression more than placebo and about as well as antidepressants, but one found signs of publication bias and others called for larger trials ^{[14, 15, 61, 62]}. Early trials gave saffron at 30 mg a day, split into two or three doses ^{[7, 59, 60]}. An umbrella review concluded that saffron cannot be considered a stand-alone treatment for depression ^[63]. Side effects in trials were no more common than with placebo, but a bleeding case with the blood thinner rivaroxaban and a link between high exposure and miscarriage mean people on blood thinners and pregnant women should talk to their doctor first ^{[15, 51, 55, 71]}.

Brad's videos on this topic

None yet.

1. Overview

Saffron is the dried stigma of the Crocus sativus flower, a plant of the Iridaceae family, and is the world's most expensive spice ^{[31, 60]}. Its main compounds are crocin, picrocrocin and safranal ^[70].

A 2015 review reports that, in animal studies, saffron and its compounds raise glutamate and dopamine levels in the brain in a dose-dependent way ^[70]. Saffron has been tested in people for depression, anxiety, sleep, memory and eye health.

Most trials are small and short, and many come from Iran ^{[14, 19]}. Meta-analyses have called for larger trials run elsewhere and found signs of publication bias ^{[14, 61]}.

2. Forms and Bioavailability

Whole Saffron vs. Standardized Extracts

Clinical trials used either saffron itself in capsules or tablets ^{[7, 48]} or branded extracts such as affron and Safr'Inside ^{[16, 27]}. Saffron's make-up varies: in one analysis, crocin content in Ukrainian saffron samples ranged from 17.80% to 33.25% ^[75].

Branded Standardized Extracts

The trials below used these branded extracts:

The UV-Vis vs. HPLC Testing Problem

The ISO 3632 standard grades saffron with a UV-vis (spectrophotometric) test. A 2017 study found no correlation between safranal measured by UV-vis and by HPLC ^[11]. UV-vis overestimated safranal, partly because it also picks up crocetin esters, and ISO quality categories did not match HPLC safranal content ^[11]. The authors judged HPLC preferable ^[11].

Solubility and Absorption

In mice, crocins taken by mouth were broken down to crocetin before or during absorption, and only crocetin and its glucuronide forms reached the blood ^[73]. In people, urine crocetin rose during 8 weeks of a saffron extract, and the rise tracked the fall in depression scores ^[20].

Whole Saffron Phytochemical Composition

Saffron and other parts of Crocus plants contain carotenoids, flavonoids, anthocyanins, terpenoids and phenol carboxylic acids ^[74]. ISO 3632 sorts saffron into quality categories using UV-vis readings, but HPLC safranal content did not follow those categories ^[11].

3. Evidence for Health Benefits

Depression and Anxiety

Meta-analytic evidence: A 2013 meta-analysis of five trials in adults with major depression found a large effect of saffron over placebo (mean effect size 1.62) and no difference from antidepressants; the authors called for larger trials run outside Iran with longer follow-up ^[14]. A 2019 meta-analysis of 23 trials found large effects on depression and anxiety compared with placebo, and as an add-on to antidepressants, but also found evidence of publication bias ^[61]. A 2020 meta-analysis of 12 studies found saffron better than placebo and as effective as antidepressants for mild to moderate depression, with no difference in side effects ^[15]. A 2025 meta-analysis of eight trials found no significant difference between saffron and SSRIs for depression, with fewer adverse events on saffron ^[62]. An umbrella review of seven meta-analyses concluded that saffron may help but cannot be considered a stand-alone treatment for depression ^[63].

Adolescent depression and anxiety (n=80, 8 weeks): In youth aged 12 to 16 years with mild to moderate symptoms of anxiety or depression, affron 14 mg twice a day cut self-rated symptom scores by an average of 33%, against 17% with placebo, with gains in separation anxiety, social phobia and depression ^[16]. Parent ratings agreed less consistently: 40% against 26% improvement on the main scale, with no other significant differences ^[16].

Adjunctive to antidepressants (n=139, 8 weeks): In adults with persistent depression already taking an antidepressant, adding affron 14 mg twice a day cut clinician-rated depression scores by 41%, against 21% with placebo ^[17]. Self-rated scores fell by 27% and 26%, so the authors called the results conflicting ^[17].

Comparison with conventional antidepressants (early pilot trials): In 6-week trials of 30 to 40 adults with mild to moderate depression, saffron 30 mg a day worked better than placebo and about as well as imipramine 100 mg a day or fluoxetine 20 mg a day ^{[7, 59, 60]}. The authors called for larger trials ^{[7, 59, 60]}.

Low Mood and Stress (Non-Clinical Depression)

Four placebo-controlled trials tested saffron extract in adults without a diagnosis of depression ^{[19, 20, 21, 22]}.

Emotional well-being, 6-week trial (n=51): In healthy adults with mild symptoms of depression, a saffron extract did not improve a combined score of depression, anxiety and fatigue, or any single symptom, compared with placebo ^[22]. Self-rated mental health on one questionnaire improved over time, which the authors said needs replication ^[22].

Low mood, 12-week trial (n=202): Adults aged 18 to 70 with depressive symptoms took affron 28 mg a day or placebo. A clinically significant fall in depression score (a drop of at least 7 points) occurred in 72.3% of the saffron group and 54.3% of the placebo group ^[19]. Other secondary outcomes did not differ, and the placebo response was large ^[19].

Low mood and stress, 8-week trial (n=56): Healthy adults aged 18 to 54 years with low mood, anxiety or stress took 30 mg of a standardised extract a day. They reported lower depression scores and better social relationships than with placebo, and a dose of saffron blunted the usual fall in heart rate variability during a lab stress test ^[20].

Acute stress response (single dose, 30 mg): In a crossover trial in 19 healthy men aged 18 to 25, a single 30 mg dose of Safr'Inside, or 0.06 mg of synthetic safranal, given before a lab stress test lowered self-rated stress and anxiety compared with placebo and delayed the peak in salivary cortisol ^[21].

Sleep

Four placebo-controlled trials have tested saffron extract for sleep ^{[24, 25, 26, 27]}.

Meta-analytic evidence: A 2022 meta-analysis of eight trials (431 people) found that saffron improved sleep quality (very low-quality evidence) and sleep duration (moderate-quality evidence), but its effect on insomnia severity was not significant ^[28]. Another 2022 meta-analysis found the most stable effect on sleep quality in a subgroup taking 100 mg a day ^[64].

Moderate insomnia, 4-week trial (n=165): Adults took Safr'Inside at 20 mg or 30 mg, or placebo. Saffron reduced insomnia symptoms (Athens Insomnia Scale) more than placebo, improved sleep quality after 3 weeks, and lowered perceived stress scores by 1.87 points (30 mg) and 1.89 points (20 mg) ^[27]. Psychological symptoms (PHQ-4) also improved with 30 mg; other measures showed no difference ^[27].

Dose comparison, 28 mg vs. 14 mg (n=120): Adults with unsatisfactory sleep took 14 mg or 28 mg of affron, or placebo, 1 hour before bed for 28 days. Both doses improved sleep quality ratings, mood on waking and insomnia symptom scores to a similar degree, but other diary and questionnaire measures did not differ from placebo ^[25]. Evening melatonin rose with saffron, and evening cortisol did not change ^[25].

Mild to moderate sleep disorder with anxiety, 6-week trial (n=66): Compared with placebo, a saffron extract at 15.5 mg a day increased time in bed measured by a wrist activity monitor (actigraphy) and sleep duration on a questionnaire ^[26]. Ease of getting to sleep, sleep quality and sleep latency improved from baseline with saffron but not with placebo; the trial reported a difference between groups only for time in bed and sleep duration ^[26].

Self-reported poor sleep, 28-day trial (n=63): In healthy adults with self-reported sleep problems, affron 14 mg twice daily improved insomnia severity, restorative sleep and sleep quality ratings more than placebo, with no reported side effects ^[24].

Cognitive Impairment and Alzheimer's Disease

A 2020 meta-analysis of four trials found that saffron improved cognitive scores compared with placebo and did not differ from standard dementia drugs, but judged the evidence too limited to recommend it ^[31]. The trials below gave saffron at 30 mg a day ^{[32, 33, 34]}.

Placebo-controlled trial in mild-to-moderate AD (16 weeks): In 46 people with mild to moderate Alzheimer's disease, saffron 15 mg twice daily gave better cognitive scores than placebo after 16 weeks, with no difference in side effects ^[32]. The authors called for larger trials ^[32].

Comparison with memantine (12 months): In 68 people with moderate to severe Alzheimer's disease, 30 mg a day of saffron extract and 20 mg a day of memantine, each taken for 12 months, gave similar results ^[33]. The trial had no placebo group ^[33].

Comparison with donepezil (22 weeks): In 54 adults aged 55 or older with mild to moderate Alzheimer's disease, saffron 15 mg twice daily worked about as well as donepezil 10 mg a day over 22 weeks, and vomiting was more common with donepezil ^[34]. The trial had no placebo arm ^[34].

Proposed mechanisms: Saffron may block the build-up of amyloid beta in the brain, which is why it was tested in Alzheimer's disease ^[32].

Vision and Age-Related Macular Degeneration

Several small studies tested saffron 20 mg a day in AMD ^{[37, 38, 39, 40]}.

Placebo-controlled trial in mild-to-moderate AMD (n=100): In a crossover trial in 100 adults over 50 years old, saffron 20 mg a day for 3 months improved best-corrected visual acuity by 0.69 letters compared with placebo, and by 0.73 letters in people already taking AREDS supplements ^[40]. Adverse events did not differ ^[40].

Retinal sensitivity, 3-month trial (crossover with placebo): In 25 people with early AMD, 3 months of saffron 20 mg a day improved retinal flicker sensitivity compared with baseline and with placebo ^[37].

Visual acuity, long-term follow-up (no placebo): In 33 people with early AMD treated for about 11 months, the benefit did not depend on the main AMD risk genes ^[39]. In an open-label study of 29 people with early AMD taking 20 mg a day, retinal sensitivity improved after 3 months and visual acuity improved by two lines on an eye chart (0.75 to 0.9); the gains held through an average of 14 (±2) months ^[38].

Weight and Appetite

Snacking reduction (n=60, 8 weeks): In mildly overweight healthy women, Satiereal 176.5 mg a day (one capsule twice daily) reduced body weight more than placebo after 8 weeks and lowered snacking frequency ^[43]. Calorie intake was not restricted ^[43].

Fatty Liver Disease (MASLD/NAFLD)

12-week trial (n=76): In adults with non-alcoholic fatty liver disease on a similar diet and activity plan, one 100 mg saffron tablet a day lowered hs-CRP, leptin and malondialdehyde (a marker of oxidative stress) and raised total antioxidant capacity compared with placebo ^[65]. Blood levels of ALT and AST, body composition and body measurements did not change ^[65].

Metabolic Effects

A 2024 meta-analysis of ten trials in 562 people with diabetes, using doses from 5 mg/day to 1 g/day, found that saffron lowered fasting glucose by 8.42 mg/dL and HbA1c by 0.22% compared with placebo, without changing insulin levels or insulin resistance ^[45]. A 2022 meta-analysis of 32 trials (1674 people) found small falls in triglycerides, total and LDL cholesterol, fasting glucose and systolic blood pressure, the last by 3.42 mmHg ^[66].

Male Sexual Health

A 2018 meta-analysis of six trials found that saffron improved erectile function scores, but results on semen quality conflicted and the trials had methodological flaws ^[46]. In an open-label crossover trial in 346 men with erectile dysfunction, 12 weeks of saffron 30 mg twice daily did not improve erectile function; the comparison was sildenafil, and there was no placebo group ^[53].

Immune Function

In healthy young men, one 100 mg saffron tablet daily (45 men, against 44 on placebo) raised IgG, lowered IgM and changed some blood cell counts at 3 weeks, but these returned to baseline by 6 weeks, and no adverse effects were reported ^[48]. The authors described the effects as temporary ^[48].

Premenstrual Syndrome (PMS)

In women aged 20 to 45 years with PMS, saffron 15 mg twice a day for two menstrual cycles relieved PMS symptoms and depression scores more than placebo ^[67].

4. Recommended Dosing

Dosing by Indication

Dosing depends on the product. These are the doses used in the trials above:

Key Dosing Principles

Doses differ by product: Trials gave affron at 14 mg twice daily, Safr'Inside at 20 mg or 30 mg, and Satiereal at 176.5 mg a day ^{[24, 27, 43]}.

Timing: In the 120-person sleep trial, affron was taken 1 hour before bed ^[25]. Depression and Alzheimer's trials split the daily dose into two or three doses ^{[7, 32, 59]}.

Duration: The shortest controlled trials lasted 4 weeks ^[27] and the longest 12 months ^[33]. An open-label AMD study ran for an average of 14 (±2) months ^[38].

Whole Saffron Powder vs. Standardized Extract

Some trials used saffron itself in capsules or tablets: 30 mg a day for depression and 100 mg a day in the fatty liver and immune trials ^{[7, 48, 65]}. Others used branded extracts (see the table above).

5. Safety and Side Effects

General Safety Profile

The longest controlled trial ran 12 months ^[33], so long-term data are limited. In depression trials, side effects were no more common with saffron than with placebo or antidepressants ^[15], and a 2025 meta-analysis found fewer adverse events with saffron than with SSRIs ^[62].

Dose-Dependent Toxicity

Side effects appear to depend on dose:

• Trial doses (extract at 14 to 30 mg a day ^{[24, 51]}, or saffron at 100 mg a day ^[48]): side effects about as common as with placebo ^{[15, 48]}.
• 200 mg or 400 mg saffron tablets for 1 week: in healthy volunteers (three groups of 10), small falls in red blood cells, haemoglobin and platelets, all within normal ranges; 400 mg lowered standing systolic blood pressure ^[68]. In another trial with three groups of 20 volunteers, the same doses did not change clotting tests ^[69].
• High doses: a European monograph quoted in a 2017 review reports no documented risk up to 1.5 g of saffron a day, poisoning from 5 g a day, and 20 g as a lethal dose ^[76]. A toxicology review lists nausea, vomiting, diarrhoea and bleeding at 1.2 to 2 g ^[51]. If someone has taken a large amount of saffron and has bleeding or severe vomiting, call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK).
• Animal LD50: median lethal doses of saffron in animal studies range from 4120 mg/kg by mouth in mice ^[51] to 20.7 g/kg ^[70].

Reported Side Effects

In trials at 30 mg a day, reported side effects included anxiety, changes in appetite, sedation, nausea, headache, dizziness, dry mouth, fatigue and hypomania, at rates not significantly different from placebo or the comparison drug ^[51].

Poisoning from 5 g a day can cause vomiting, bloody diarrhoea, blood in the urine, bleeding into the skin of the nose, lips and eyelids, vertigo and yellowing of the skin and mucous membranes ^[76].

Blood Thinning Effects

Trials found small falls in platelets but no change in clotting tests ^{[48, 68, 69]}.

Case report, bleeding with an anticoagulant: A man aged 64 who was taking rivaroxaban had sudden nosebleeds and bleeding gums after starting a saffron supplement ^[55]. The authors advised against combining saffron with DOACs (direct oral anticoagulants, such as rivaroxaban) and called for larger studies ^[55].

Platelet count changes: A week of 200 mg or 400 mg saffron tablets slightly lowered platelets, within normal ranges ^[68]. At 100 mg a day, platelets fell from baseline at 3 weeks and returned to baseline by 6 weeks ^[48]. Clotting tests (PT, PTT, fibrinogen, factor VII, and proteins C and S) did not change with 200 mg or 400 mg saffron tablets for a week ^[69].

Special Population Concerns

Bipolar disorder: Hypomania, a mild form of mania, was recorded in a few people taking saffron in depression and Alzheimer's trials, at rates similar to the comparison groups ^[51]. People with bipolar disorder should ask their doctor before taking saffron.

Pregnancy: Higher doses of saffron, or heavy exposure at work, have been linked to uterine stimulation and more miscarriages ^[71]. More than 5 g can stimulate the uterus ^[76]. Women between the first and twentieth week of pregnancy who were exposed to high levels of saffron while harvesting it had a higher miscarriage rate than controls ^[51]. At term, three 250 mg doses of saffron in 24 hours made the cervix more ready for labour ^[72]. Clinical trials on safety in pregnancy are lacking, and a toxicology review advises pregnant women to avoid high doses ^[51]. Avoid saffron supplements during pregnancy unless your doctor advises them. Safety while breastfeeding is not established.

Children and adolescents: One 8-week trial gave affron 14 mg twice a day to youth aged 12 to 16 years, and it was well tolerated ^[16]. Evidence in children is limited.

Adulteration Risks

Saffron's high price makes it a target for fraud. A 2026 systematic review of 23 studies estimated that 20% to 30% of commercial saffron is adulterated worldwide, from 3.5% in regulated EU markets to 60% in India ^[56]. Common practices include swapping in safflower, marigold or turmeric, diluting with other plant material, and adding synthetic dyes such as Sudan dyes and auramine-O; health risks include exposure to dyes that can cause cancer ^[56]. The authors of a 2017 study judged HPLC preferable to UV-vis for measuring safranal ^[11].

6. Drug Interactions

Blood Thinners (Anticoagulants and Antiplatelets)

A man on rivaroxaban had bleeding after adding saffron, and the case report's authors advised against combining saffron with DOACs ^[55]. Saffron may add to the effect of other blood thinners too. If you take an anticoagulant (warfarin, rivaroxaban, apixaban, dabigatran) or an antiplatelet drug (aspirin, clopidogrel), ask your doctor before taking saffron. For bleeding that will not stop, call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK).

Antidepressant Medications

In an 8-week trial in adults already taking antidepressants, adding affron did not increase antidepressant side effects ^[17]. In theory, saffron could add to the serotonin effects of SSRIs (such as fluoxetine or sertraline), SNRIs (such as venlafaxine or duloxetine) or MAOIs and raise the risk of serotonin syndrome, so ask your doctor before combining them. Signs of serotonin syndrome include agitation, confusion, a fast heartbeat, high temperature, heavy sweating and muscle twitching or stiffness; if they appear, call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK). Do not stop or swap an antidepressant for saffron without your doctor's advice: saffron cannot be considered a stand-alone treatment for depression ^[63].

Sedative Medications

Saffron raised evening melatonin in one sleep trial ^[25]. In theory, it could add to the effect of sedative medicines such as benzodiazepines, zolpidem or sedating antihistamines.

Antihypertensive Medications

Saffron lowered systolic blood pressure by 3.42 mmHg in a 2022 meta-analysis ^[66], and 400 mg saffron tablets lowered standing systolic pressure in healthy volunteers ^[68]. People taking blood pressure medicines should watch for an added fall in blood pressure.

Diabetes Medications

Saffron slightly lowered fasting glucose and HbA1c in people with diabetes ^[45]. If you take glucose-lowering medicines (metformin, sulfonylureas, insulin), check your blood glucose more often when starting saffron, to catch low blood sugar.

7. Dietary Sources

Saffron is widely used in food for its colour, taste and smell ^[51].